11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now

2. AbbVie Inc. (NYSE:ABBV)

Number of Hedge Fund Investors: 68              

The biopharmaceutical business AbbVie Inc. (NYSE:ABBV) focuses on developing and marketing innovative therapies, such as cosmetic and dermatological products. The company, being one of the Best Aesthetics Stocks, offers aesthetic procedures like BOTOX Cosmetic and JUVÉDERM dermal fillers to treat wrinkles and facial volume loss.

Revenue increased 4% year over year in Q3 2024, showing robust growth in the Skyrizi, Rinvoq, and Neuroscience portfolios. The aesthetics portfolio generated $1.239 billion in net revenues worldwide. While global Juvederm net revenues decreased 19.7% year over year to $258 million, global Botox Cosmetic net revenues increased by 8.2% to $671 million.

Significant market expansions were made by Allergan Aesthetics when it received FDA approval for its platysma band-targeting Botox Cosmetic and introduced its masseter muscle prominence (MMP) treatment in China. At the ASDS conference, AbbVie Inc. (NYSE:ABBV) also presented its modern research and patient-centered tactics.

The firm increased its adjusted EPS outlook for 2024 to $10.90-$10.94, excluding IPR&D and milestone expenses incurred after Q3 and the upcoming Aliada Therapeutics acquisition.

In October of this year, AbbVie Inc. (NYSE:ABBV) increased its quarterly dividend by about 6% to $1.64 per share. The firm extended its dividend growth streak to 52 years with this increase.

Ken Griffin’s Citadel Investment Group was the largest stakeholder in the company from among the funds in Insider Monkey’s database. It owns over 2.4 million shares worth $487.28 million as of Q3.